RUN vs VYNE · P/E 6.0, rev $1.59B vs rev $501.0K
Sunrun Inc (RUN) versus Vyne Therapeutics Inc (VYNE) — a side-by-side from cached financials, not a winner call.
Sunrun Inc (RUN) is a solar company listed on NASDAQ.
Vyne Therapeutics Inc (VYNE) is a biotechnology company listed on NASDAQ.
Latest reported RUN revenue for 2026-06-30 was $1.59B. Net income was $282.8M. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
Latest reported VYNE revenue for 2024-12-31 was $501.0K. Net income was -$39.8M. Revenue was up 18.2% from 2023-12-31 to 2024-12-31. VYNE currently screens at market cap $21.1M.
RUN currently screens at market cap $3.05B and trailing P/E 6.0. VYNE currently screens at market cap $21.1M.
Not investment advice. Open the RUN and VYNE stock pages for the full models.
Not investment advice.